Evolved.Bio
PrivateLast Round
Seed
May 19, 2022
Total Funding Raised
$2M
Company Overview
Evolved.Bio operates in Healthcare & Life Sciences and is based in Kitchener, Ontario. Its latest recorded funding round was a Seed round in May 2022.
Evolved.Bio is a biotechnology company that develops scaffold- and biomaterial-free tissues using its Anchored Cell Sheet Engineering platform for applications in drug discovery, cellular agriculture, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolved.Bio Comparables
Compare Evolved.Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspect Biosystems | 72% | |
| TissueByNet Corporation | 71% | |
| CellSeed Inc. | 70% |
For institutional investors. Book with your work email.
Evolved.Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evolved.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saltagen Ventures | Seed |
| Maple Leaf Foods | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
Evolved.Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evolved.Bio's valuation, stock price, and market status.
Is Evolved.Bio a public or private company?
Evolved.Bio is a private company.
What is the current stock price of Evolved.Bio?
Evolved.Bio is a private company, so its shares have no public market price. Caplight tracks Evolved.Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evolved.Bio worth (valuation)?
Valuation information for Evolved.Bio is not publicly available.
Can I buy Evolved.Bio stock?
Evolved.Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evolved.Bio's last funding round?
Evolved.Bio's most recent funding round was Seed on May 19, 2022.
Who are the main investors in Evolved.Bio?
Key investors in Evolved.Bio include Saltagen Ventures, Maple Leaf Foods.
Will Evolved.Bio IPO soon?
No public IPO plans have been announced for Evolved.Bio.
How can I track Evolved.Bio secondary market activity?
Caplight tracks bids, offers, and trades in Evolved.Bio's shares on secondary markets.